Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents - PubMed (original) (raw)
Involvement of 5-HT₇ receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
Ligia Westrich et al. Neuropharmacology. 2015 Feb.
Free article
Abstract
Since poor circadian synchrony and cognitive dysfunction have been linked to affective disorders, antidepressants that target key 5-HT (serotonin) receptor subtypes involved in circadian rhythm and cognitive regulation may have therapeutic utility. Vortioxetine is a multimodal antidepressant that inhibits 5-HT1D, 5-HT3, 5-HT7 receptor activity, 5-HT reuptake, and enhances the activity of 5-HT1A and 5-HT1B receptors. In this study, we investigated the effects of vortioxetine on the period length of PER2::LUC expression, circadian behavior, and episodic memory, using tissue explants from genetically modified PER2::LUC mice, locomotor activity rhythm monitoring, and the object recognition test, respectively. Incubation of tissue explants from the suprachiasmatic nucleus of PER2::LUC mice with 0.1 μM vortioxetine increased the period length of PER2 bioluminescence. Monitoring of daily wheel-running activity of Sprague-Dawley rats treated with vortioxetine (10 mg/kg, s.c.), alone or in combination with the 5-HT1A receptor agonist flesinoxan (2.5 mg/kg, s.c.) or the 5-HT7 receptor antagonist SB269970 (30 mg/kg, s.c.), just prior to activity onset revealed significant delays in wheel-running behavior. The increase in circadian period length and the phase delay produced by vortioxetine were abolished in the presence of the 5-HT7 receptor partial agonist AS19. Finally, in the object recognition test, vortioxetine (10 mg/kg, i.p.) increased the time spent exploring the novel object during the retention test and this effect was prevented by AS19 (5 mg/kg, i.p.). In conclusion, the present study shows that vortioxetine, partly via its 5-HT7 receptor antagonism, induced a significant effect on circadian rhythm and presented promnesic properties in rodents.
Similar articles
- The effects of combining serotonin reuptake inhibition and 5-HT7 receptor blockade on circadian rhythm regulation in rodents.
Westrich L, Sprouse J, Sánchez C. Westrich L, et al. Physiol Behav. 2013 Feb 17;110-111:42-50. doi: 10.1016/j.physbeh.2012.12.009. Epub 2012 Dec 28. Physiol Behav. 2013. PMID: 23276605 - Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
Jensen JB, du Jardin KG, Song D, Budac D, Smagin G, Sanchez C, Pehrson AL. Jensen JB, et al. Eur Neuropsychopharmacol. 2014 Jan;24(1):148-59. doi: 10.1016/j.euroneuro.2013.10.011. Epub 2013 Nov 4. Eur Neuropsychopharmacol. 2014. PMID: 24284262 - A study of time- and sex-dependent effects of vortioxetine on rat sexual behavior: Possible roles of direct receptor modulation.
Li Y, Pehrson AL, Oosting RS, Gulinello M, Olivier B, Sanchez C. Li Y, et al. Neuropharmacology. 2017 Jul 15;121:89-99. doi: 10.1016/j.neuropharm.2017.04.017. Epub 2017 Apr 13. Neuropharmacology. 2017. PMID: 28414050 - [Pharmacological properties of vortioxetine and its pre-clinical consequences].
David DJ, Tritschler L, Guilloux JP, Gardier AM, Sanchez C, Gaillard R. David DJ, et al. Encephale. 2016 Feb;42(1 Suppl 1):1S12-23. doi: 10.1016/S0013-7006(16)30015-X. Encephale. 2016. PMID: 26879252 Review. French.
Cited by
- Chronic Stress-induced Serotonin Impairs Intestinal Epithelial Cell Mitochondrial Biogenesis via the AMPK-PGC-1α Axis.
Yang D, Sun Y, Wen P, Chen Y, Cao J, Sun X, Dong Y. Yang D, et al. Int J Biol Sci. 2024 Aug 19;20(11):4476-4495. doi: 10.7150/ijbs.97275. eCollection 2024. Int J Biol Sci. 2024. PMID: 39247815 Free PMC article. - Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1.
Torrisi SA, Geraci F, Tropea MR, Grasso M, Caruso G, Fidilio A, Musso N, Sanfilippo G, Tascedda F, Palmeri A, Salomone S, Drago F, Puzzo D, Leggio GM, Caraci F. Torrisi SA, et al. Front Pharmacol. 2019 Jun 21;10:693. doi: 10.3389/fphar.2019.00693. eCollection 2019. Front Pharmacol. 2019. PMID: 31293421 Free PMC article. - Cognitive impairment in depression: recent advances and novel treatments.
Perini G, Cotta Ramusino M, Sinforiani E, Bernini S, Petrachi R, Costa A. Perini G, et al. Neuropsychiatr Dis Treat. 2019 May 10;15:1249-1258. doi: 10.2147/NDT.S199746. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31190831 Free PMC article. Review. - Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism.
Felice D, Guilloux JP, Pehrson A, Li Y, Mendez-David I, Gardier AM, Sanchez C, David DJ. Felice D, et al. Front Pharmacol. 2018 Mar 12;9:204. doi: 10.3389/fphar.2018.00204. eCollection 2018. Front Pharmacol. 2018. PMID: 29593535 Free PMC article. - Influence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the Literature.
Orzechowska A, Filip M, Gałecki P. Orzechowska A, et al. Med Sci Monit. 2015 Nov 24;21:3643-51. doi: 10.12659/msm.895156. Med Sci Monit. 2015. PMID: 26599597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical